Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition.
about
Twist1 is a potential prognostic marker for colorectal cancer and associated with chemoresistance.Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancerTwist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancerMithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells.Multiple biological functions of Twist1 in various cancers.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.Carnosine Inhibits the Proliferation of Human Gastric Carcinoma Cells by Retarding Akt/mTOR/p70S6K Signaling.Paradoxical functions of ZEB1 in EGFR-mutant lung cancer: tumor suppressor and driver of therapeutic resistance.Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK/mTOR pathway in breast cancer.A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer.Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.[Effect of PI3K/AKT pathway on cisplatin resistance in non-small cell lung cancer].
P2860
Q35929842-C43E8AA4-607B-4E89-BB75-F8212E7E84A1Q36420021-EC957A7D-B4D9-47D7-A607-B5DBBC0BDE2BQ36544114-FCA7DE5D-83ED-4B32-BD3B-C05C93F790C4Q36545047-A0F6C472-8454-4DF1-BF43-ADFBBDA37249Q37176520-D30B9903-681B-4609-87C1-23CFEEB5B7D0Q37746336-24134B2F-5D07-4EF0-A379-96B63C436A68Q38885892-F4849782-DFC0-4EFC-97FE-7665C2A02894Q39147611-FA27BD87-BEF4-42FB-AC95-AEB17DBFDF94Q39717744-6B855212-D7E8-4615-9FDF-280DBC794B8DQ47634621-525FAB9F-687F-4F52-9D22-C55BBC02668CQ47887010-C6B203E5-DD04-47B5-8BAB-705FA38A4F97Q47942760-15556340-527D-47F8-9C42-5FDA3FC3FD3AQ54329431-1713A147-45B4-4D97-883A-95D5D589E2ED
P2860
Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@ast
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@en
type
label
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@ast
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@en
prefLabel
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@ast
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@en
P2093
P2860
P356
P1476
Silencing of Twist1 sensitizes ...... MPK-activated mTOR inhibition.
@en
P2093
P2860
P2888
P356
10.1038/CDDIS.2012.63
P577
2012-06-07T00:00:00Z
P5875
P6179
1018938251